EUCTR2011-004418-40-BE进行中（未招募）不适用
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female patients at or older than 18 years and who have relapsed Glioblastoma after first-line treatment with chemoradiation, have measureable disease (response to be based on RANO criteria), and Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 110
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
排除标准
- •Moderate or severe cardiac condition. Prior treatment with nitrosurea. Prior treatment with bevacizumab as part of a first-line treatment for GB, Serious concomitant systemic disorder, Current acute or chronic myelogenous leukemia, Second primary malignancy, Pregnant or breast-feeding women
研究者
相似试验
进行中（未招募）
不适用
A Study in Recurrent GlioblastomaGlioblastomaEUCTR2011-004418-40-NLEli Lilly and Company180
进行中（未招募）
1 期
A Study in Recurrent GlioblastomaGlioblastomaEUCTR2011-004418-40-PLEli Lilly and Company180
已完成
2 期
A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent GlioblastomaNL-OMON37449Eli Lilly10
进行中（未招募）
1 期
A Study in Recurrent GlioblastomaGlioblastomaEUCTR2011-004418-40-DEEli Lilly and Company180
进行中（未招募）
不适用
A Study in Recurrent GlioblastomaMedDRA version: 14.1Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2011-004418-40-ESilly S.A,180